Exin Therapeutics, Inc. — Form D

Exin Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-02-10. The offering totals $2.2M, of which $2.2M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2026-02-10
• Form: D
• Accession: 0002109179-26-000001
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $2.2M
• Amount sold: $2.2M
• Investors: 28
• Date of first sale: 2024-11-18
• Revenue range: Decline to Disclose
• SEC file number: 021-573167

Issuer

• Name: Exin Therapeutics, Inc.
• CIK: 0002109179
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2024
• Address: 2261 MARKET STREET STE 22614, SAN FRANCISCO, CA, 94114
• Phone: (650) 942-3715

Officers, directors & promoters (6)

More

• CIK 2109179 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search